The general surgery devices market was valued at USD 18.4 billion in 2024 and is estimated at USD 21.5 billion in 2026. It is forecast to reach USD 30.0 billion by 2030, growing at a CAGR of 8.5% from 2025 to 2030, according to Grand View Research. North America held the largest share, at 38.2% of 2024 revenue.

How large is the general surgery devices market, and where is the money?

By our own calculation, the 2030 forecast sits about USD 11.6 billion above the 2024 base. Three segments carry most of the weight. Disposable surgical supplies are the largest type, with around 47.1% of 2024 revenue. Orthopedic surgery is the largest application, at around 20.7%. Hospitals are the largest end-use setting, at 58.1%.

The leaders and the fastest growers are different segments. Medical robotics and computer-assisted devices are projected to grow fastest by type. Cardiology is projected to grow fastest by application. Ambulatory surgical centers are projected to grow fastest by end use over 2025 to 2030. The general surgery devices market therefore earns most of its revenue from established consumables and orthopedics, while growth is shifting toward technology-heavy and outpatient segments.

Market projections referenced in this article are drawn from Grand View Research. To explore the data further, try their Prism AI tool.

Key Market Insights & Drivers: what is pushing demand?

More surgeries. About 310 million major surgeries are performed worldwide every year, according to a 2020 NCBI article. Europe alone accounts for roughly 20 million. Nearly 30 million children and teenagers play youth sports each year, and the report links that to surgical emergencies.

A change in disease patterns. Health problems are shifting from infectious diseases toward lifestyle-related conditions, including cardiovascular disease, cancers, cerebrovascular disease and bone disorders. The report also points to growing accident-related injuries as vehicle and gadget use rises. Cardiovascular disease caused 20.5 million deaths in 2021 and affected more than 500 million people, nearly one-third of all deaths worldwide.

Older populations. Several figures in the report show how fast this is moving:

• China expected people aged 60 and above to be about 21.1% of its population by 2024.
• The UK’s 85-plus group is set to grow by one million between 2021 and 2036.
• Saudi Arabia’s 65-plus population is expected to reach about 4 million by 2030.
• Latin America’s 65-plus share was about 9% in 2024 and is projected to double by 2050.

Technology and awareness. The report lists RFID and blockchain technologies, rising demand from emerging nations and greater awareness of surgical options among its key drivers. Robotic and computer-assisted surgery is still early-stage but gaining momentum, with current use in cholecystectomy, fundoplication and Heller myotomy.

Portable instruments. Higher chronic-disease risk and rising hospital costs are pushing more people toward home healthcare using portable surgical equipment, which supports growth in developed regions.

The main restraint is cost. Advanced devices need heavy investment to buy and maintain, which limits growth in emerging and underdeveloped areas.

Download a free sample report or claim your copy of this full market intelligence report

Which general surgery devices are most common?

The report’s segmentation shows the range of the product base.

Disposable surgical supplies are the biggest group. They include surgical masks, drapes, caps and gowns, examination and surgical gloves, procedural kits, needles and syringes, and venous access catheters. Hygiene, infection control and compliance with safety rules drive their use. Solvay’s September 2022 partnership with French startup Ostium on materials for single-use instruments shows the segment’s design focus.

Open surgery instruments cover retractors, dilators and catheters. These are mature products, and quality manufacturing is what separates suppliers. In September 2023, Acrotec Group acquired Friedrich Daniels, a German maker of surgical instruments.

Energy-based and powered instruments include powered staplers and drill systems. In September 2022, Olympus launched its THUNDERBEAT Open Fine Jaw Type X for open surgeries such as thyroidectomy.

Minimally invasive instruments, such as laparoscopes and organ retractors, are growing as laparoscopic procedures replace open surgery.

Medical robotics and computer-assisted devices are the fastest-growing type. The FDA approved the Hominis Surgical System in March 2021 for transvaginal hysterectomy in specific patients. In 2024, DePuy Synthes launched a robotics system and standalone navigation platform with eCential Robotics (August), and Smith+Nephew signed a co-marketing deal with JointVue (October).

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs

Who buys these devices?

The U.S. has about 6,200 operating hospitals (AHA, 2024), which perform millions of procedures a year. Ambulatory surgical centers are fewer but growing fast, with about 9,600 operating in the U.S. in 2025 (Definitive Healthcare). Same-day surgery, cost savings and shorter waits are driving their demand for minimally invasive instruments.

Which regions lead the general surgery devices market?

North America leads on healthcare investment, hospital networks, reimbursement policy and the presence of major manufacturers. Europe is growing rapidly. In France, healthcare spending was about 12.31% of GDP in 2021, and around 4 million people live with cardiovascular disease. Germany is noted for its high-quality device manufacturers. In Asia Pacific, China, India and Japan are key contributors. In the Middle East, medical tourism in Saudi Arabia and the UAE is lifting demand for minimally invasive and robotic systems. Erbe Elektromedizin opened a new production facility in Rangendingen, Germany, in May 2024.

Who competes in the general surgery devices market?

The market has moderate to high concentration. The profiled companies are Medtronic, Johnson & Johnson, Conmed, Integra LifeSciences, Smith & Nephew, BD, B. Braun, Cadence, Integer Holdings, Olympus, Stryker, Boston Scientific, Erbe Elektromedizin and 3M Healthcare. They compete through new products, collaborations, acquisitions and regional expansion. FDA and EMA approval requirements raise the cost of entry but also build trust.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

What should readers take away?

The general surgery devices market grows on surgical volume, so it is less exposed to single-technology risk. The practical question for suppliers is which setting they serve, because hospitals hold the most revenue while ambulatory centers are growing fastest.

Check Out Our Dedicated Business Offerings –

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today